Usefulness of the SAMe-TT2R2 risk score in identifying patients who will do well with vitamin K antagonist therapy in a community-based cohort of patients with non-valvular atrial fibrillation
Fecha de publicación
2014Título de revista
European Heart Journal
Tipo de contenido
Publicación de congreso